p16 Expression as a predictive biomarker of hypoxic cell-sensitizing agents in oropharyngeal cancer
- PMID: 20697096
- DOI: 10.1200/JCO.2010.30.6035
p16 Expression as a predictive biomarker of hypoxic cell-sensitizing agents in oropharyngeal cancer
Comment on
-
Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.J Clin Oncol. 2010 Sep 20;28(27):4142-8. doi: 10.1200/JCO.2010.29.2904. Epub 2010 Aug 9. J Clin Oncol. 2010. PMID: 20697079 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
